Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn's disease patient himself has supercharged his mission to help revolutionize the research process.
Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson's mission to improve health for people across the globe for over a century.
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.
For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Mental Health Awareness Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.